Takeaway

• Combined noradrenergic antimuscarinic agents are efficacious for treating obstructive sleep apnea (OSA), according to a meta-analysis.

Why this matters

• There is currently no pharmacotherapy in routine use for OSA.
• The success of this therapy supports the rationale that key contributors to OSA are endogenous norepinephrine withdrawal, especially during nonrapid...